About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Digital Health & Omnichannel Strategy >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey

Learn more
Join Putnam
Insights

Contact

Latest thinking.

Explore our latest insights and perspectives in these life science resources, news articles, and events.

Scroll

Topic

Content Type

Navigating the Joint Clinical Assessment (JCA) with ...

Navigate the JCA launch with Putnam's expert strategies. Unlock optimal market access with PICO-driven insights, evidence plans & regulatory synergy.

Key outcomes of ASCO24

Our experts shared key themes for #ASCO24 and now summarize the vital insights on antibody drug conjugates, radiopharmaceuticals, and bispecifics.

BD&L strategy for oncology leadership

Our experts take a deep dive into the growing oncology market uncovering the top drivers and activities of revenue growth.

The expanding concept of value – Implications for ma...

Micro-tutorial on payer value drivers, tackling challenges in their integration into payer/HTA frameworks and generating robust supporting evidence.

Preparing for ASH 2023: Heme-oncology research &...

We’re sharing some spotlights to help support our clients and partners navigate ASH 2023.

Spotlight on antibody drug conjugates (ADCs)

ADCs continued to be a spotlight at ESMO 2023. The team shares its key value drivers and associated limitations.

Promoting technical excellence in HEOR and market ac...

We shared micro-tutorials at ISPOR Europe on nine critical scientific and strategic topics related to HTA. Contact us to discuss more.

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.